{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:28:10Z","timestamp":1793460490526,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP17K09699"],"award-info":[{"award-number":["JP17K09699"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mesenchymal stem cells (MSCs) administered for therapeutic purposes can be activated by interferon-\u03b3 (IFN-\u03b3) secreted from natural killer cells in injured tissues and exert anti-inflammatory effects. These processes require a substantial period of time, leading to a delayed onset of MSCs\u2019 therapeutic effects. In this study, we investigated whether pretreatment with IFN-\u03b3 could potentiate the anti-fibrotic ability of MSCs in rats with ischemia\u2013reperfusion injury (IRI) and unilateral ureter obstruction. Administration of MSCs treated with IFN-\u03b3 strongly reduced infiltration of inflammatory cells and ameliorated interstitial fibrosis compared with control MSCs without IFN-\u03b3 treatment. In addition, conditioned medium obtained from IFN-\u03b3-treated MSCs decreased fibrotic changes in cultured cells induced by transforming growth factor-\u03b21 more efficiently than that from control MSCs. Most notably, secretion of prostaglandin E2 from MSCs was significantly increased by treatment with IFN-\u03b3. Increased prostaglandin E2 in conditioned medium obtained from IFN-\u03b3-treated MSCs induced polarization of immunosuppressive CD163 and CD206-positive macrophages. In addition, knockdown of prostaglandin E synthase weakened the anti-fibrotic effects of MSCs treated with IFN-\u03b3 in IRI rats, suggesting the involvement of prostaglandin E2 in the beneficial effects of IFN-\u03b3. Administration of MSCs treated with IFN-\u03b3 might represent a promising therapy to prevent the progression of renal fibrosis.<\/jats:p>","DOI":"10.1038\/s41598-020-79664-6","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T11:26:43Z","timestamp":1610537203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Interferon-\u03b3 enhances the therapeutic effect of mesenchymal stem cells on experimental renal fibrosis"],"prefix":"10.1038","volume":"11","author":[{"given":"Ryo","family":"Kanai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumu","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehiro","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoe","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Ishiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"key":"79664_CR1","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","volume":"382","author":"V Jha","year":"2013","unstructured":"Jha, V. et al. Chronic kidney disease: global dimension and perspectives. Lancet 382, 260\u2013272 (2013).","journal-title":"Lancet"},{"key":"79664_CR2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.kint.2018.04.011","volume":"94","author":"Y Xie","year":"2018","unstructured":"Xie, Y. et al. Analysis of the global burden of disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 94, 567\u2013581 (2018).","journal-title":"Kidney Int."},{"key":"79664_CR3","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1038\/ki.2010.418","volume":"78","author":"SB Lee","year":"2010","unstructured":"Lee, S. B. & Kalluri, R. Mechanistic connection between inflammation and fibrosis. Kidney Int. 78, S22\u2013S26 (2010).","journal-title":"Kidney Int."},{"key":"79664_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrneph.2014.114","volume":"10","author":"XM Meng","year":"2014","unstructured":"Meng, X. M., Nikolic-Paterson, D. J. & Lan, H. Y. Inflammatory processes in renal fibrosis. Nat. Rev. Nephrol. 10, 493\u2013503 (2014).","journal-title":"Nat. Rev. Nephrol."},{"key":"79664_CR5","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1681\/ASN.2010080793","volume":"21","author":"M Zeisberg","year":"2010","unstructured":"Zeisberg, M. & Neilson, E. G. Mechanisms of tubulointerstitial fibrosis. J. Am. Soc. Nephrol. 21, 1819\u20131834 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"79664_CR6","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1681\/ASN.2010040430","volume":"22","author":"DL Rosin","year":"2011","unstructured":"Rosin, D. L. & Okusa, M. D. Dangers within: DAMP responses to damage and cell death in kidney disease. J. Am. Soc. Nephrol. 22, 416\u2013425 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"79664_CR7","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1681\/ASN.2014010117","volume":"25","author":"HJ Anders","year":"2014","unstructured":"Anders, H. J. & Schaefer, L. Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis. J. Am. Soc. Nephrol. 25, 1387\u20131400 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"79664_CR8","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.7314\/APJCP.2012.13.4.1365","volume":"13","author":"Q He","year":"2012","unstructured":"He, Q. et al. HMGB1 promotes the synthesis of pro-IL-1\u03b2 and pro-IL-18 by activation of p38 MAPK and NF-\u03baB through receptors for advanced glycation end-products in macrophages. Asian Pac. J. Cancer Prev. 13, 1365\u20131370 (2012).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"79664_CR9","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1093\/ndt\/gfv358","volume":"31","author":"S Zewinger","year":"2016","unstructured":"Zewinger, S., Schumann, T., Fliser, D. & Speer, T. Innate immunity in CKD-associated vascular diseases. Nephrol. Dial. Transplant. 31, 1813\u20131821 (2016).","journal-title":"Nephrol. Dial. Transplant."},{"key":"79664_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger, M. F. et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143\u2013147 (1999).","journal-title":"Science"},{"key":"79664_CR11","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/jcb.20886","volume":"98","author":"AI Caplan","year":"2006","unstructured":"Caplan, A. I. & Dennis, J. E. Mesenchymal stem cells as trophic mediators. J. Cell Biochem. 98, 1076\u20131084 (2006).","journal-title":"J. Cell Biochem."},{"key":"79664_CR12","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.biocel.2008.01.007","volume":"40","author":"Y Chen","year":"2008","unstructured":"Chen, Y., Shao, J. Z., Xiang, L. X., Dong, X. J. & Zhang, G. R. Mesenchymal stem cells: a promising candidate in regenerative medicine. Int. J. Biochem. Cell Biol. 40, 815\u2013820 (2008).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"79664_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cytogfr.2009.10.002","volume":"20","author":"ML daSilva","year":"2009","unstructured":"daSilva, M. L., Fontes, A. M., Covas, D. T. & Caplan, A. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 20, 419\u2013427 (2009).","journal-title":"Cytokine Growth Factor Rev."},{"key":"79664_CR14","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.yexcr.2010.05.009","volume":"316","author":"AM Hocking","year":"2011","unstructured":"Hocking, A. M. & Gibran, N. S. Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair. Exp Cell Res. 316, 2213\u20132219 (2011).","journal-title":"Exp Cell Res."},{"key":"79664_CR15","doi-asserted-by":"publisher","first-page":"e0148542","DOI":"10.1371\/journal.pone.0148542","volume":"11","author":"M Gregorini","year":"2016","unstructured":"Gregorini, M. et al. Mesenchymal stromal cells prevent renal fibrosis in a rat model of unilateral ureteral obstruction by suppressing the renin-angiotensin system via HuR. PLoS ONE 11, e0148542. https:\/\/doi.org\/10.1371\/journal.pone.0148542 (2016).","journal-title":"PLoS ONE"},{"key":"79664_CR16","doi-asserted-by":"publisher","first-page":"F25","DOI":"10.1152\/ajprenal.00311.2016","volume":"312","author":"F Matsui","year":"2017","unstructured":"Matsui, F. et al. Mesenchymal stem cells protect against obstruction-induced renal fibrosis by decreasing STAT3 activation and STAT3-dependent MMP-9 production. Am. J. Physiol. Renal. Physiol. 312, F25\u2013F32 (2017).","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"79664_CR17","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.jss.2010.06.022","volume":"168","author":"H Asanuma","year":"2011","unstructured":"Asanuma, H. et al. Arterially delivered mesenchymal stem cells prevent obstruction-induced renal fibrosis. J. Surg. Res. 168, e51\u2013e59 (2011).","journal-title":"J. Surg. Res."},{"key":"79664_CR18","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.1038\/s41598-019-41100-9","volume":"9","author":"C Grange","year":"2019","unstructured":"Grange, C. et al. Stem cell-derived extracellular vesicles inhibit and revert fibrosis progression in a mouse model of diabetic nephropathy. Sci. Rep. 9, 4468. https:\/\/doi.org\/10.1038\/s41598-019-41100-9 (2019).","journal-title":"Sci. Rep."},{"key":"79664_CR19","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1089\/scd.2007.0276","volume":"17","author":"E Meng","year":"2008","unstructured":"Meng, E. et al. High mobility group box 1 protein inhibits the proliferation of human mesenchymal stem cells and promotes their migration and differentiation along osteoblastic pathway. Stem Cell Dev. 17, 805\u2013813 (2008).","journal-title":"Stem Cell Dev."},{"key":"79664_CR20","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3892\/ijmm.2016.2479","volume":"37","author":"F Lin","year":"2016","unstructured":"Lin, F. et al. Signaling pathways involved in the effects of HMGB1 on mesenchymal stem cell migration and osteoblastic differentiation. Int. J. Mol. Med. 37, 789\u2013797 (2016).","journal-title":"Int. J. Mol. Med."},{"key":"79664_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/143463","author":"H Thomas","year":"2014","unstructured":"Thomas, H. et al. (2014) Interaction with mesenchymal stem cells provokes natural killer cells for enhanced IL-12\/IL-18-induced interferon-gamma secretion. Mediat. Inflamm. https:\/\/doi.org\/10.1155\/2014\/143463 (2014).","journal-title":"Mediat. Inflamm."},{"key":"79664_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s13287-017-0730-z","volume":"8","author":"T Lin","year":"2017","unstructured":"Lin, T. et al. Preconditioning of murine mesenchymal stem cells synergistically enhanced immunomodulation and osteogenesis. Stem Cell Res Ther. 8, 277. https:\/\/doi.org\/10.1186\/s13287-017-0730-z (2017).","journal-title":"Stem Cell Res Ther."},{"key":"79664_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/icb.2012.56","volume":"91","author":"K English","year":"2013","unstructured":"English, K. Mechanisms of mesenchymal stromal cell immunomodulation. Immunol. Cell Biol. 91, 19\u201326 (2013).","journal-title":"Immunol. Cell Biol."},{"key":"79664_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.imlet.2007.04.001","volume":"110","author":"K English","year":"2007","unstructured":"English, K., Barry, F. P., Field-Corbett, C. P. & Mahon, B. P. IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells. Immunol. Lett. 110, 91\u2013100 (2007).","journal-title":"Immunol. Lett."},{"key":"79664_CR25","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.clim.2010.01.015","volume":"135","author":"K Chen","year":"2010","unstructured":"Chen, K. et al. Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism. Clin. Immunol. 135, 448\u2013458 (2010).","journal-title":"Clin. Immunol."},{"key":"79664_CR26","doi-asserted-by":"publisher","first-page":"e12862","DOI":"10.1111\/cpr.12862","volume":"53","author":"Y Wei","year":"2020","unstructured":"Wei, Y. et al. High-efficient generation of VCAM-1+ mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice. Cell Prolif. 53, e12862. https:\/\/doi.org\/10.1111\/cpr.12862 (2020).","journal-title":"Cell Prolif."},{"key":"79664_CR27","doi-asserted-by":"publisher","first-page":"15642","DOI":"10.1073\/pnas.1519644112","volume":"112","author":"B Luan","year":"2015","unstructured":"Luan, B. et al. CREB pathway links PGE2 signaling with macrophage polarization. Proc. Natl. Acad. Sci. USA 112, 15642\u201315647 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"79664_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12967-019-1999-8","volume":"17","author":"L Jin","year":"2019","unstructured":"Jin, L. et al. Mesenchymal stem cells promote type 2 macrophage polarization to ameliorate the myocardial injury caused by diabetic cardiomyopathy. J. Transl. Med. 17, 251. https:\/\/doi.org\/10.1186\/s12967-019-1999-8 (2019).","journal-title":"J. Transl. Med."},{"key":"79664_CR29","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/sctm.17-0284","volume":"7","author":"K Yoshida","year":"2018","unstructured":"Yoshida, K. et al. Serum-free medium enhances the immunosuppressive and antifibrotic abilities of mesenchymal stem cells utilized in experimental renal fibrosis. Stem Cells Transl. Med. 7, 893\u2013905 (2018).","journal-title":"Stem Cells Transl. Med."},{"key":"79664_CR30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13287-020-01642-6","volume":"11","author":"N Ishiuchi","year":"2020","unstructured":"Ishiuchi, N. et al. Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats. Stem Cell Res. Ther. 11, 130. https:\/\/doi.org\/10.1186\/s13287-020-01642-6 (2020).","journal-title":"Stem Cell Res. Ther."},{"key":"79664_CR31","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1681\/ASN.2009101048","volume":"21","author":"W Huiling","year":"2010","unstructured":"Huiling, W. et al. HMGB1 contributes to kidney ischemia reperfusion injury. J. Am. Soc. Nephrol. 21, 1878\u20131890 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"79664_CR32","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41374-018-0162-0","volume":"99","author":"K Sakai","year":"2019","unstructured":"Sakai, K. et al. Protective effect and mechanism of IL-10 on renal ischemia\u2013reperfusion injury. Lab Invest. 99, 671\u2013683 (2019).","journal-title":"Lab Invest."},{"key":"79664_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature00858","volume":"418","author":"P Scaffidi","year":"2002","unstructured":"Scaffidi, P., Misteli, T. & Bianchi, M. E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191\u2013195 (2002).","journal-title":"Nature"},{"key":"79664_CR34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nri1594","volume":"5","author":"MT Lotze","year":"2005","unstructured":"Lotze, M. T. & Tracey, K. J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5, 331\u2013342 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"79664_CR35","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1586\/1744666X.2014.909730","volume":"10","author":"B Lu","year":"2014","unstructured":"Lu, B. et al. Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review. Expert Rev. Clin. Immunol. 10, 713\u2013727 (2014).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"79664_CR36","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1042\/BJ20051106","volume":"393","author":"MK Phanish","year":"2006","unstructured":"Phanish, M. K., Wahab, N. A., Colville-Nash, P., Hendry, B. M. & Dockrell, M. E. C. The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximal-tubule epithelial cells. Biochem J. 393, 601\u2013607 (2006).","journal-title":"Biochem J."},{"key":"79664_CR37","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/jb\/mvq043","volume":"147","author":"A Yoshimura","year":"2010","unstructured":"Yoshimura, A., Wakabayashi, Y. & Mori, T. Cellular and molecular basis for the regulation of inflammation by TGF-\u03b2. J Biochem. 147, 781\u2013792 (2010).","journal-title":"J Biochem."},{"key":"79664_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/ki.2013.81","volume":"84","author":"T Ueno","year":"2013","unstructured":"Ueno, T. et al. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-\u03b21 signaling. Kidney Int. 84, 297\u2013307 (2013).","journal-title":"Kidney Int."},{"key":"79664_CR39","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1128\/MCB.02168-07","volume":"28","author":"A Nakashima","year":"2008","unstructured":"Nakashima, A. et al. DEC1 modulates the circadian phase of clock gene expression. Mol. Cell Biol. 28, 4080\u20134092 (2008).","journal-title":"Mol. Cell Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79664-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79664-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79664-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T01:43:21Z","timestamp":1670031801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79664-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["79664"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-79664-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]},"assertion":[{"value":"3 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Department of Stem Cell Biology and Medicine, Graduate School of Biomedical & Health Sciences, Hiroshima University is a collaborative research laboratory funded by TWOCELLS Company, Limited. Dr. Maeda is the Deputy Division Manager of R&D Division II, Head Office of Research and Development of TWOCELLS Company, Limited. Emeritus Prof. Kato is the Vice President of TWOCELLS Company, Limited. Except for the abovementioned disclosures, all authors have declared that no conflict of interest exists.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"850"}}